The effect of induction chemotherapy in patients with locally advanced nonsmall cell lung cancer who received chemoradiotherapy
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference29 articles.
1. Global cancer statistics;Jemal;CA Cancer J Clin,2011
2. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classifi cation of malignant tumours;Goldstraw;J Thorac Oncol,2007
3. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III nonsmall-cell lung cancer;Eberhardt;Ann Oncol,2015
4. Definitive and adjuvant radiotherapy in locally advanced non-small-cell lung cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline;Bezjak;J Clin Oncol,2015
5. Sequential radio-chemotherapy (RT-CT) versus radiotherapy alone (RT) and concomitant RT-CT versus RT alone in locally advanced nonsmall cell lung cancer (NSCLC): two metaanalyses using individual patient data (IPD) from randomised clinical trials (RCTs);Rolland;J Thorac Oncol,2007
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tumor to liver maximum standardized uptake value ratio of FDG-PET/CT parameters predicts tumor treatment response and survival of stage III non-small cell lung cancer;BMC Medical Imaging;2023-08-15
2. Optimum cycles of induction chemotherapy in concurrent chemo-radiotherapy management of unresectable stage III non-small cell lung cancer: Results from a single institutional database;Medicine;2023-05-12
3. Treatment patterns and long‐term survival outcomes for patients with stage III non‐small cell lung cancer: A retrospective study;Asia-Pacific Journal of Clinical Oncology;2023-02
4. Pathological response to neoadjuvant therapy with chemotherapy vs chemoradiotherapy in stage III NSCLC. Contribution of IASLC recommendations;World Journal of Clinical Oncology;2021-11-24
5. Efficacy and safety of S-1 maintenance therapy in advanced non-small-cell lung cancer patients;World Journal of Clinical Cases;2020-11-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3